X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-10-18 | NPCE | Neuropace Inc | Kck Ltd. | 10% | S - Sale | $6.21 | -8,598 | 5,499,065 | 0% | -$53,370 | |||||
| M | 2024-10-18 | SGHT | Sight Sciences, Inc. | Link Matthew | Chief Commercial Officer | S - Sale | $5.79 | -42,318 | 663,550 | -6% | -$244,901 | |||||
2024-10-17 | LUNG | Pulmonx Corp | French Glendon E. III | Dir | S - Sale | $6.52 | -20,000 | 1,091,974 | -2% | -$130,400 | ||||||
2024-10-18 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.75 | +8,104 | 15,605,252 | 0% | +$6,062 | ||||||
| M | 2024-10-16 | SGHT | Sight Sciences, Inc. | Link Matthew | Chief Commercial Officer | S - Sale | $5.87 | -41,704 | 705,868 | -6% | -$244,878 | |||||
2024-10-16 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $45.02 | -40,000 | 601,233 | -6% | -$1,800,835 | ||||||
| D | 2024-10-16 | GMED | Globus Medical Inc | Huller Kelly | SVP, GC, Corporate Secretary | S - Sale+OE | $75.02 | -7,500 | 0 | -100% | -$562,649 | |||||
2024-10-16 | GMED | Globus Medical Inc | Davidar David D | Dir | S - Sale | $75.04 | -50,000 | 722,242 | -6% | -$3,751,813 | ||||||
| M | 2024-10-03 | NPCE | Neuropace Inc | Kck Ltd. | 10% | S - Sale | $6.53 | -46,426 | 5,507,663 | -1% | -$303,367 | |||||
| D | 2024-10-15 | PRCT | Procept Biorobotics Corp | Waters Kevin | EVP, CFO | S - Sale+OE | $72.47 | -25,000 | 96,096 | -21% | -$1,811,653 | |||||
2024-10-10 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.74 | +6,234 | 15,597,148 | 0% | +$4,632 | ||||||
| D | 2024-10-11 | RMD | Resmed Inc | Ghoshal Kaushik | Chief Commercial Officer, SaaS | S - Sale+OE | $238.48 | -4,260 | 21,788 | -16% | -$1,015,925 | |||||
2024-10-08 | STIM | Neuronetics, Inc. | Furlong Stephen | EVP, CFO, Treasurer | S - Sale | $0.82 | -1,368 | 497,408 | 0% | -$1,122 | ||||||
2024-10-08 | STIM | Neuronetics, Inc. | Macan William Andrew | EVP, GC, CCO, CS | S - Sale | $0.82 | -1,541 | 402,792 | 0% | -$1,264 | ||||||
| M | 2024-10-07 | ANGO | Angiodynamics Inc | Nighan Warren Jr | SVP Quality, Regulatory | P - Purchase | $6.09 | +868 | 45,877 | +2% | +$5,285 | |||||
2024-10-08 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $233.47 | -1,000 | 95,812 | -1% | -$233,470 | ||||||
| D | 2024-10-07 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $231.92 | -14,683 | 468,259 | -3% | -$3,405,206 | |||||
2024-10-08 | ANGO | Angiodynamics Inc | Trowbridge Stephen A | EVP, CFO | P - Purchase | $5.86 | +1,700 | 172,711 | +1% | +$9,962 | ||||||
| D | 2024-10-07 | BSX | Boston Scientific Corp | Mahoney Michael F | COB, Pres, CEO | S - Sale+OE | $84.63 | -162,777 | 1,781,374 | -8% | -$13,775,792 | |||||
| D | 2024-10-07 | BSX | Boston Scientific Corp | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $85.00 | -132,527 | 165,361 | -44% | -$11,264,888 | |||||
2024-10-07 | ANGO | Angiodynamics Inc | Clemmer James C | Pres, CEO | P - Purchase | $6.03 | +20,000 | 681,582 | +3% | +$120,600 | ||||||
| M | 2024-10-02 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $13.58 | -4,226 | 232,491 | -2% | -$57,403 | |||||
2024-10-02 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $13.58 | -3,305 | 197,062 | -2% | -$44,886 | ||||||
2024-10-02 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO | S - Sale | $5.99 | -12,727 | 5,725,433 | 0% | -$76,184 | ||||||
2024-10-01 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $6.08 | -4,878 | 158,687 | -3% | -$29,658 | ||||||
2024-10-02 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $5.99 | -3,167 | 1,756,481 | 0% | -$18,958 | ||||||
2024-10-01 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | CFO | S - Sale | $6.08 | -10,130 | 392,555 | -3% | -$61,590 | ||||||
2024-10-01 | SGHT | Sight Sciences, Inc. | Park Sam Boong | COO | S - Sale | $6.08 | -3,403 | 254,826 | -1% | -$20,690 | ||||||
2024-10-02 | PEN | Penumbra Inc | Grewal Harpreet | Dir | S - Sale | $190.83 | -166 | 8,697 | -2% | -$31,678 | ||||||
2024-10-01 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $190.76 | -600 | 60,488 | -1% | -$114,456 | ||||||
2024-10-01 | PEN | Penumbra Inc | Kassing Don W. | Dir | S - Sale | $193.93 | -170 | 9,335 | -2% | -$32,968 | ||||||
2024-10-02 | AXNX | Axonics, Inc. | Keese Kari Leigh | CFO | S - Sale | $69.41 | -2,961 | 40,362 | -7% | -$205,512 | ||||||
| M | 2024-08-30 | NPCE | Neuropace Inc | Kck Ltd. | 10% | S - Sale | $6.92 | -39,684 | 5,554,089 | -1% | -$274,714 | |||||
| M | 2024-09-30 | VERO | Venus Concept Inc. | Masters Michael Willingham | 10% | S - Sale | $0.59 | -306,135 | 743,912 | -29% | -$179,641 | |||||
| D | 2024-10-01 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale+OE | $26.18 | -12,430 | 139,989 | -8% | -$325,415 | |||||
| D | 2024-10-01 | BSX | Boston Scientific Corp | Carruthers Wendy | EVP, HR | S - Sale+OE | $83.86 | -6,983 | 34,748 | -17% | -$585,594 | |||||
2024-10-02 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $237.20 | -2,000 | 85,204 | -2% | -$474,400 | ||||||
2024-10-01 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.75 | +5,744 | 15,590,914 | 0% | +$4,319 | ||||||
| D | 2024-09-26 | XAIR | Beyond Air, Inc. | Carey Robert | Dir | P - Purchase | $0.50 | +1,476,626 | 1,476,626 | New | +$744,662 | |||||
| D | 2024-09-26 | XAIR | Beyond Air, Inc. | Lisi Steven A. | CEO, COB | P - Purchase | $0.50 | +1,476,626 | 3,249,411 | +83% | +$744,662 | |||||
| D | 2024-10-01 | ICUI | Icu Medical Inc/de | Jain Vivek | COB, CEO | S - Sale+OE | $178.47 | -12,000 | 193,291 | -6% | -$2,141,580 | |||||
2024-09-30 | ICU | Seastar Medical Holding Corp | Chung Kevin | Chief Medical Officer | P - Purchase | $4.26 | +1,000 | 9,435 | +12% | +$4,258 | ||||||
2024-09-30 | RDGL | Vivos Inc | Korenko Michael K | CEO, Pres | P - Purchase | $0.16 | +50,000 | 10,385,090 | 0% | +$7,955 | ||||||
2024-09-25 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.73 | +9,663 | 15,585,170 | 0% | +$7,021 | ||||||
| M | 2024-09-24 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $4.79 | +10,000 | 914,640 | +1% | +$47,905 | |||||
2024-09-23 | INFU | Infusystem Holdings, Inc | Eichenbaum Kenneth D. | Dir | P - Purchase | $5.89 | +4,000 | 4,000 | New | +$23,560 | ||||||
2024-09-20 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale | $197.71 | -15,000 | 887,582 | -2% | -$2,965,646 | ||||||
| D | 2024-01-22 | VAPO | Vapotherm Inc | Liken James W | Dir | S - Sale+OE | $0.91 | -17,500 | 0 | -100% | -$15,957 | |||||
2024-09-20 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.82 | +71,422 | 15,575,507 | 0% | +$58,859 | ||||||
| M | 2024-09-18 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.89 | +28,890 | 15,504,085 | 0% | +$25,627 | |||||
2024-09-18 | AURX | Nuo Therapeutics, Inc. | Sheedy Charles E | 10% | P - Purchase | $0.75 | +125,000 | 11,440,865 | +1% | +$93,750 | ||||||
2024-09-12 | LUNG | Pulmonx Corp | French Glendon E. III | Dir | S - Sale | $8.09 | -20,000 | 1,111,974 | -2% | -$161,800 | ||||||
| D | 2024-09-16 | PRCT | Procept Biorobotics Corp | Waters Kevin | EVP, CFO | S - Sale+OE | $82.51 | -25,000 | 96,096 | -21% | -$2,062,679 | |||||
2024-09-16 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $45.83 | -40,000 | 643,296 | -6% | -$1,833,188 | ||||||
2024-09-16 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.90 | +450 | 15,475,195 | 0% | +$404 | ||||||
| DM | 2024-09-13 | SYK | Stryker Corp | Fink M Kathryn | VP, CHRO | S - Sale+OE | $367.66 | -9,468 | 10,440 | -48% | -$3,480,956 | |||||
2024-09-16 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $5.31 | +50,000 | 11,847,224 | 0% | +$265,630 | ||||||
2024-09-13 | TTOO | T2 Biosystems, Inc. | Elsbree David B | Dir | S - Sale | $2.42 | -55 | 25 | -69% | -$133 | ||||||
| D | 2024-09-13 | GMED | Globus Medical Inc | Rhoads Ann D | Dir | S - Sale+OE | $70.36 | -15,000 | 42,884 | -26% | -$1,055,400 | |||||
| D | 2024-09-13 | GMED | Globus Medical Inc | Davidar David D | Dir | S - Sale+OE | $70.46 | -25,000 | 772,242 | -3% | -$1,761,500 | |||||
2024-09-16 | DXCM | Dexcom Inc | Heller Bridgette P | Dir | S - Sale | $70.00 | -1,000 | 24,349 | -4% | -$70,000 | ||||||
2024-09-13 | PSTV | Plus Therapeutics, Inc. | Hawkins Richard J | Dir | P - Purchase | $1.50 | +4,000 | 15,188 | +36% | +$5,996 | ||||||
2024-09-13 | CTCX | Carmell Corp | Upton Richard A | Dir | P - Purchase | $0.47 | +5,000 | 1,432,279 | 0% | +$2,336 | ||||||
2024-09-12 | PSTV | Plus Therapeutics, Inc. | Hawkins Richard J | Dir | P - Purchase | $1.35 | +6,285 | 11,188 | +128% | +$8,512 | ||||||
| D | 2024-09-12 | GUTS | Fractyl Health, Inc. | Caplan Jay David | Pres, Chief Product Officer | S - Sale+OE | $2.90 | -65,000 | 508,100 | -11% | -$188,474 | |||||
| M | 2024-09-12 | TLSI | Trisalus Life Sciences, Inc. | Szela Mary T | CEO, Pres | P - Purchase | $5.09 | +14,815 | 384,677 | +4% | +$75,359 | |||||
2024-09-12 | STIM | Neuronetics, Inc. | Cascella Robert | Dir | P - Purchase | $0.75 | +100,000 | 453,098 | +28% | +$75,000 | ||||||
| D | 2024-09-12 | NARI | Inari Medical, Inc. | Hill, Mitch C. | CFO | S - Sale+OE | $45.13 | -3,000 | 181,200 | -2% | -$135,385 | |||||
| D | 2024-09-12 | RMD | Resmed Inc | Ghoshal Kaushik | Chief Commercial Officer, SaaS | S - Sale+OE | $252.56 | -5,000 | 21,788 | -19% | -$1,262,800 | |||||
2024-09-11 | PSTV | Plus Therapeutics, Inc. | Petersen Greg | Dir | P - Purchase | $1.35 | +12,500 | 48,921 | +34% | +$16,875 | ||||||
2024-09-11 | PSTV | Plus Therapeutics, Inc. | Clowes Howard | Dir | P - Purchase | $1.34 | +5,000 | 26,497 | +23% | +$6,681 | ||||||
| M | 2024-09-10 | PRCT | Procept Biorobotics Corp | Desai Antal Rohit | Dir | S - Sale | $78.09 | -120,065 | 197,453 | -38% | -$9,375,595 | |||||
2024-09-10 | TLSI | Trisalus Life Sciences, Inc. | Szela Mary T | CEO, Pres | P - Purchase | $4.97 | +5,000 | 369,862 | +1% | +$24,850 | ||||||
| M | 2024-09-10 | DRIO | Dariohealth Corp. | Nelson Steven Charles | Chief Commercial Officer | P - Purchase | $0.82 | +10,000 | 50,000 | +25% | +$8,244 | |||||
| D | 2024-09-11 | PODD | Insulet Corp | Hopfield Jessica | Dir | S - Sale+OE | $225.26 | -7,628 | 26,917 | -22% | -$1,718,283 | |||||
2024-08-27 | HRGN | Harvard Apparatus Regenerative Technology, Inc. | He Junli | CEO | P - Purchase | $3.37 | +5,101 | 259,701 | +2% | +$17,190 | ||||||
| D | 2024-09-09 | GKOS | Glaukos Corp | Kliman Gilbert H | Dir | S - Sale+OE | $130.67 | -3,000 | 32,336 | -8% | -$392,000 | |||||
2024-09-09 | DXCM | Dexcom Inc | Stern Sadie | EVP, CHRO | S - Sale | $69.15 | -426 | 75,451 | -1% | -$29,458 | ||||||
2024-09-09 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP, Chief Financal Officer | S - Sale | $69.15 | -746 | 84,274 | -1% | -$51,586 | ||||||
2024-09-09 | DXCM | Dexcom Inc | Leach Jacob Steven | EVP, COO | S - Sale | $69.15 | -746 | 312,211 | 0% | -$51,586 | ||||||
| M | 2024-09-09 | SSII | Ss Innovations International, Inc. | Cohen Barry F | COO - Americas | P - Purchase | $3.91 | +622 | 8,959,903 | 0% | +$2,430 | |||||
2024-09-09 | INSP | Inspire Medical Systems, Inc. | McCormick Shawn | Dir | S - Sale | $220.00 | -800 | 26,140 | -3% | -$176,000 | ||||||
2024-09-09 | INSP | Inspire Medical Systems, Inc. | Rondoni John | CTO | S - Sale | $215.00 | -31 | 11,348 | 0% | -$6,665 | ||||||
| D | 2024-09-06 | BEAT | Heartbeam, Inc. | De Urioste George | Dir | S - Sale+OE | $2.34 | -1,674 | 57,146 | -3% | -$3,917 | |||||
2024-09-10 | PODD | Insulet Corp | Scannell Timothy J | Dir | S - Sale | $225.84 | -5,000 | 30,586 | -14% | -$1,129,200 | ||||||
2024-09-10 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.91 | +8,577 | 15,474,745 | 0% | +$7,812 | ||||||
2024-09-10 | PSTV | Plus Therapeutics, Inc. | Hedrick Marc H | CEO | P - Purchase | $1.23 | +8,000 | 20,425 | +64% | +$9,839 | ||||||
2024-09-10 | PSTV | Plus Therapeutics, Inc. | Sims Andrew John Hugh Macintyre | CFO | P - Purchase | $1.27 | +4,098 | 9,815 | +72% | +$5,204 | ||||||
2024-09-09 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $246.42 | -1,000 | 96,812 | -1% | -$246,420 | ||||||
| D | 2024-09-09 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $248.38 | -14,683 | 468,259 | -3% | -$3,646,950 | |||||
| M | 2024-09-09 | OBIO | Orchestra Biomed Holdings, Inc. | Sherman Darren | See Remarks | S - Sale | $5.39 | -13,708 | 1,538,478 | -1% | -$73,946 | |||||
| M | 2024-09-06 | OBIO | Orchestra Biomed Holdings, Inc. | Fain Eric S | Dir | S - Sale | $5.48 | -5,600 | 86,020 | -6% | -$30,666 | |||||
2024-08-28 | TLSI | Trisalus Life Sciences, Inc. | Martin George Kelly | Dir | S - Sale | $5.50 | -9 | 247,176 | 0% | -$50 | ||||||
2024-09-06 | CTCX | Carmell Corp | Gregory Kathryn | Dir | P - Purchase | $0.51 | +1,260 | 84,757 | +2% | +$643 | ||||||
2024-09-06 | CTCX | Carmell Corp | Sturgeon Patrick A | Dir | P - Purchase | $0.51 | +1,261 | 135,910 | +1% | +$643 | ||||||
2024-09-10 | CTCX | Carmell Corp | Cassaday Bryan J. | CFO | P - Purchase | $0.46 | +475 | 35,500 | +1% | +$219 | ||||||
2024-09-06 | CTCX | Carmell Corp | Frisch Scott M. | Dir | P - Purchase | $0.51 | +1,009 | 28,419 | +4% | +$515 | ||||||
2024-09-06 | CTCX | Carmell Corp | Spenlehauer Gilles | Dir | P - Purchase | $0.51 | +1,009 | 28,419 | +4% | +$515 | ||||||
2024-09-09 | PODD | Insulet Corp | Field Mark N | SVP, CTO | S - Sale | $220.87 | -1,383 | 9,761 | -12% | -$305,463 | ||||||
2024-09-09 | PODD | Insulet Corp | Budden Lauren | Group VP, CAO, Controller | S - Sale | $221.41 | -1,506 | 6,609 | -19% | -$333,443 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |